Kristie Wagner
Nessuna posizione attualmente
Storia della carriera di Kristie Wagner
Precedenti posizioni note di Kristie Wagner
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/11/2013 | 01/02/2021 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Comptroller/Controller/Auditor | 01/06/2021 | - |
| Direttore Finanziario/CFO | 24/02/2022 | - |
Formazione di Kristie Wagner
| Suffolk University | Masters Business Admin |
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Kristie Wagner
- Esperienza
